# | Title | Journal | Year | Citations |
---|
|
1 | Lung volumes and forced ventilatory flows | European Respiratory Journal | 1993 | 4,830 |
2 | Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations | European Respiratory Journal | 2012 | 4,415 |
3 | Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | European Respiratory Journal | 2004 | 3,831 |
4 | International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma | European Respiratory Journal | 2014 | 3,015 |
5 | International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods | European Respiratory Journal | 1995 | 2,915 |
6 | Haemodynamic definitions and updated clinical classification of pulmonary hypertension | European Respiratory Journal | 2019 | 2,789 |
7 | Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis | European Respiratory Journal | 2020 | 2,664 |
8 | 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension | European Respiratory Journal | 2015 | 2,490 |
9 | Development and first validation of the COPD Assessment Test | European Respiratory Journal | 2009 | 2,409 |
10 | Development and validation of a questionnaire to measure asthma control | European Respiratory Journal | 1999 | 2,060 |
11 | An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease | European Respiratory Journal | 2014 | 1,761 |
12 | The European Community Respiratory Health Survey | European Respiratory Journal | 1994 | 1,466 |
13 | Systemic manifestations and comorbidities of COPD | European Respiratory Journal | 2009 | 1,394 |
14 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 | European Respiratory Journal | 2019 | 1,307 |
15 | Global burden of COPD: systematic review and meta-analysis | European Respiratory Journal | 2006 | 1,202 |
16 | Chronic obstructive pulmonary disease: molecular and cellularmechanisms | European Respiratory Journal | 2003 | 1,188 |
17 | Effects of systemic steroids in patients with severe community-acquired pneumonia | European Respiratory Journal | 2007 | 1,179 |
18 | Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study | European Respiratory Journal | 2020 | 1,145 |
19 | Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure | European Respiratory Journal | 2017 | 1,067 |
20 | The forced oscillation technique in clinical practice: methodology, recommendations and future developments | European Respiratory Journal | 2003 | 1,036 |
21 | Increased amount of nitric oxide in exhaled air of asthmatics | European Respiratory Journal | 1993 | 1,000 |
22 | Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC) | European Respiratory Journal | 1998 | 990 |
23 | Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update | European Respiratory Journal | 2003 | 954 |
24 | Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD | European Respiratory Journal | 2008 | 935 |
25 | Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults | European Respiratory Journal | 1993 | 891 |
26 | Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review | European Respiratory Journal | 2009 | 891 |
27 | 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) | European Respiratory Journal | 2019 | 890 |
28 | Pirfenidone in idiopathic pulmonary fibrosis | European Respiratory Journal | 2010 | 884 |
29 | Mortality in COPD: role of comorbidities | European Respiratory Journal | 2006 | 880 |
30 | International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Journal | 2017 | 877 |
31 | Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study | European Respiratory Journal | 2000 | 868 |
32 | Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives | European Respiratory Journal | 2019 | 855 |
33 | European Respiratory Society guidelines for the management of adult bronchiectasis | European Respiratory Journal | 2017 | 853 |
34 | An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features | European Respiratory Journal | 2015 | 849 |
35 | Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS) | European Respiratory Journal | 1996 | 844 |
36 | Prevalence and rate of diagnosis of allergic rhinitis in Europe | European Respiratory Journal | 2004 | 841 |
37 | Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes | European Respiratory Journal | 2008 | 840 |
38 | A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease | European Respiratory Journal | 2002 | 830 |
39 | Six minute walking distance in healthy elderly subjects | European Respiratory Journal | 1999 | 829 |
40 | Oxidative stress and regulation of glutathione in lung inflammation | European Respiratory Journal | 2000 | 812 |
41 | Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease | European Respiratory Journal | 2003 | 804 |
42 | Treatable traits: toward precision medicine of chronic airway diseases | European Respiratory Journal | 2016 | 782 |
43 | Pulmonary-Hepatic vascular Disorders (PHD) | European Respiratory Journal | 2004 | 767 |
44 | Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD | European Respiratory Journal | 2004 | 767 |
45 | Systemic effects of chronic obstructive pulmonary disease | European Respiratory Journal | 2003 | 760 |
46 | Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities | European Respiratory Journal | 2006 | 744 |
47 | Epidemiological evidence of effects of coarse airborne particles on health | European Respiratory Journal | 2005 | 730 |
48 | WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update | European Respiratory Journal | 2011 | 728 |
49 | The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics | European Respiratory Journal | 2001 | 727 |
50 | The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma | European Respiratory Journal | 2003 | 726 |